Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease()

Amyloid imaging is currently introduced to the market for clinical use. We will review the evidence demonstrating that the different amyloid PET ligands that are currently available are valid biomarkers for Alzheimer-related β amyloidosis. Based on recent findings from cross-sectional and longitudin...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandenberghe, Rik, Adamczuk, Katarzyna, Dupont, Patrick, Laere, Koen Van, Chételat, Gaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777773/
https://www.ncbi.nlm.nih.gov/pubmed/24179802
http://dx.doi.org/10.1016/j.nicl.2013.03.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777773/
https://www.ncbi.nlm.nih.gov/pubmed/24179802
http://dx.doi.org/10.1016/j.nicl.2013.03.014

Ejemplares similares